CSE/AIDR (CSE/AIDR)

Canadian Securities Exchange: CSE/AIDR · CAD

CA$0.46

-0.01 (-2.1%)· Recorded snapshot

Market cap	48.5M
Revenue (ttm)	38.1K
Net income (ttm)	-2M
EPS (ttm)	-CA$0.17
Shares out	105.5M
Volume	26,970
Beta	-0.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.1K
Net income (ttm): -2M
EPS (ttm): -CA$0.17
Market cap: 48.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/AIDR indicators

Market & fundamental data

Available fields

146

Groups with data

Currency

CAD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-30
Employees change	0
Employees growth	0%
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2024-03-31
First seen	2026-05-10
Fiscal year end	December
Founded	2018
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA7729241066
Last earnings date	2025-12-05
Last refreshed	2026-10-28
Last stock split date	2023-07-14
Last stock split type	Reverse
Market cap	CAD 48.5M
Next earnings date	2026-10-30
Price	CAD 0.46
Price currency	CAD
Sector	Healthcare
SIC code	7372
Stock price date	2026-10-28
Symbol	cse/AIDR
Website	https://www.treatment.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-36.62%
P/S ratio	1,300.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	63.43%
Operating margin	-5,080.2%
Pretax margin	-5,268.63%
ROA	-221.31%
ROA (5Y)	-515.98%
ROCE	291.26%
SBC / revenue	883.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -1.9M
EPS	CAD -0.17
Financing cash flow	CAD 1M
Gross profit	CAD 24,190
Net borrowing	CAD 31,320
Net cash flow	CAD 847,614
Net income	CAD -2M
Operating cash flow minus SBC	CAD -536,998
Operating income	CAD -1.9M
Revenue	CAD 38,136
Stock-based compensation	CAD 337,033

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-39.52
Book value per share	CAD -0.02
Interest coverage	-21.7
Long-term assets	CAD -1.7M
Long-term liabilities	CAD 191,442
Net cash (debt)	CAD 288,222
Net cash / market cap	0.58%
Piotroski F-Score	2
Shareholders' equity	CAD -665,178
Tangible book value	CAD -665,178
Tangible book value per share	CAD -0.02
Total assets	CAD 1M
Total cash	CAD 897,393
Total debt	CAD 609,171
Total liabilities	CAD 1.7M
WACC	2.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.07
Current assets	CAD 2.7M
Current liabilities	CAD 1.5M
Current ratio	0.61
Net working capital	CAD -953,400
Quick ratio	0.54
Working capital	CAD -665,178
Working capital turnover	-0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-78.95%
Shareholder yield	-78.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.59
1D price change	-2.13%
1M price change	-20.69%
1M total return	-20.69%
1W price change	-4.17%
1W total return	-4.17%
1Y price change	-47.73%
1Y return CAGR	-47.75%
1Y total return	-47.73%
20-day SMA	CAD 0.52
200-day SMA	CAD 0.62
3M price change	-24.59%
3M total return	-24.59%
3Y price change	-2.13%
3Y return CAGR	-0.71%
3Y total return	-2.13%
50-day SMA	CAD 0.56
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.98
52-week high date	2025-11-07
52-week low	CAD 0.45
52-week low date	2026-10-26
5Y price change	-98.16%
5Y return CAGR	-55.03%
5Y total return	-98.16%
6M price change	-19.3%
6M total return	-19.3%
All-time high	CAD 63.00
All-time high date	2021-05-20
All-time low	CAD 0.10
All-time low date	2023-05-23
Average true range (ATR)	CAD 0.03
Average volume	101.6K
Beta (1Y)	0.66
Beta (2Y)	0.39
Beta (5Y)	-0.25
Change from 52-week high	-53.06%
Change from 52-week low	2.22%
Change from all-time high	-99.27%
Change from all-time low	360%
Change from open	-2.13%
Day's gap	0%
Dollar volume	CAD 12,406
High price	CAD 0.48
Low price	CAD 0.46
Monthly RSI	23.06
Open price	CAD 0.47
Position in 52-week range	0%
Previous close	CAD 0.47
Price vs 150-day SMA	-22.31%
Price vs 20-day SMA	-11.79%
Price vs 200-day SMA	-25.55%
Price vs 50-day SMA	-18.21%
Relative volume	0.27
RSI	31
Sharpe ratio	-0.67
Sharpe ratio (3Y)	0.79
Sortino ratio	-0.95
Sortino ratio (3Y)	1.63
Volume	27K
Weekly RSI	34.49
YTD price change	-36.99%
YTD total return	-36.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101.2M
Shares change (QoQ)	437.87%
Shares held by insiders	4.06%
Shares held by institutions	0.23%
Shares outstanding	105.5M

Deeper analysis on CSE/AIDR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/AIDR report

Is a complete CSE/AIDR research report available?

No complete published report is available for cse/AIDR (CSE/AIDR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/AIDR (CSE/AIDR)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/AIDR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/AIDR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/AIDR

Frequently asked questions